IVAN ACEVEDO: Open Payments
NPI 1659122539 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $282 · 2025 $946
Food & beverage: $836Education: $109
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $226 |
| Teva Pharmaceuticals USA, Inc. | 7 | $205 |
| Lundbeck LLC | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 3 | $96 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $25 |
| Tris Pharma Inc | 1 | $22 |
Products named: Auvelity, REXULTI, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, TRINTELLIX, VRAYLAR.
Industry payments across FL — which companies pay providers there.
